Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02575534Withdrawn
Open-label, single-arm trial of procainamide in cardiac arrhythmia. Primary endpoints: Change in QRS duration, Changes in left ventricular volumes and 2 more. Planned start Oct 2015; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02575534.